Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Apr 20:9:129.
doi: 10.3389/fnins.2015.00129. eCollection 2015.

Neuropsychiatric disorders in Cushing's syndrome

Affiliations
Review

Neuropsychiatric disorders in Cushing's syndrome

Rosario Pivonello et al. Front Neurosci. .

Abstract

Endogenous Cushing's syndrome (CS), a rare endocrine disorder characterized by cortisol hypersecretion, is associated with psychiatric and neurocognitive disorders. Major depression, mania, anxiety, and neurocognitive impairment are the most important clinical abnormalities. Moreover, patients most often complain of impairment in quality of life, interference with family life, social, and work performance. Surprisingly, after hypercortisolism resolution, despite the improvement of the overall prevalence of psychiatric and neurocognitive disorders, the brain volume loss at least partially persists and it should be noted that some patients may still display depression, anxiety, panic disorders, and neurocognitive impairment. This brief review aimed at describing the prevalence of psychiatric and neurocognitive disorders and their characterization both during the active and remission phases of CS. The last section of this review is dedicated to quality of life, impaired during active CS and only partially resolved after resolution of hypercortisolism.

Keywords: Cushing's syndrome; cognitive impairment; neurological disorders; psychiatric disorders; quality of life.

PubMed Disclaimer

References

    1. Arnaldi G., Angeli A., Atkinson A. B., Bertagna X., Cavagnini F., Chrousos G. P., et al. . (2003). Diagnosis and complications of Cushing's syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 88, 5593–5602. 10.1210/jc.2003-030871 - DOI - PubMed
    1. Bourdeau I., Bard C., Noël B., Leclerc I., Cordeau M. P., Bélair M., et al. . (2002). Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism. J. Clin. Endocrinol. Metab. 87, 1949–1954. 10.1210/jc.87.5.1949 - DOI - PubMed
    1. Clayton R. N. (2010). Mortality and morbidity in Cushing's disease. Neuroendocrinology 92 Suppl. 1, 71–76 10.1159/000315813 - DOI - PubMed
    1. Cohen S. I. (1980). Cushing's syndrome: a psychiatric study of 29 patients. Br. J. Psychiatry 136, 120–124. 10.1192/bjp.136.2.120 - DOI - PubMed
    1. Colao A., Cozzolino A., Pivonello R. (2012). Quality of life in patients with Cushing's disease: a modern approach. Clin. Endocrinol. (Oxf.) 76, 776–777. 10.1111/j.1365-2265.2012.04344.x - DOI - PubMed

LinkOut - more resources